Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-26 @ 10:34 AM
NCT ID:
NCT04476628
Eligibility Criteria:
Inclusion Criteria:
1. Patients aged between 19 years and above
2. Patients with chronic or recurrent sinusitis (as defined by the American Academy of Otolaryngology) with or without nasal polyposis or allergic fungal rhinosinusitis.
3. Patients currently on budesonide or being prescribed budesonide for the first time
4. Minimum Modified Lund Kennedy score of 2.
Exclusion Criteria:
1. Individuals unable to understand the purpose, methods and conduct of this study
2. Patients unwilling to provide informed consent
3. Are immuno-compromised, and have impairment in mucociliary function (e.g., cystic fibrosis, Kartagener syndrome)
4. Have autoimmune diseases affecting the upper airway (eg Systemic lupus erythematosus, Sjögren's syndrome, systemic sclerosis etc)
5. Have sinonasal tumors
6. Patients with a history of pituitary disease
7. Patients with a known hypersensitivity to cortisol, corticotropin, or cosyntropin
8. Recent use of systemic corticosteroids such as prednisone (within last 3 months)
9. Patients who are pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT04476628
Study Brief:
Protocol Section:
NCT04476628